news Melatonin could act as barrier against SARS-CoV-2 infection 28 January 2021 | By Victoria Rees (Drug Target Review) Researchers have suggested using melatonin in a nasal spray to create a protective barrier against SARS-CoV-2 in pre-symptomatic patients.
news Drug target to tackle COVID-19 inflammatory processes identified 2 December 2020 | By Victoria Rees (Drug Target Review) Researchers have shown that the presence of the inflammasome mediated by NLRP3 is a marker and drug target for COVID-19-related cytokine storms.
news CNS tumour aggressiveness reduced with new molecule 8 November 2019 | By Rachael Harper (Drug Target Review) A microRNA inhibitor has been identified which reduced the sizes of aggressive CNS tumours and improved survival in mice.
news Biomarkers may help provide personalised treatment for brain cancer 13 April 2018 | By Drug Target Review Researchers in Brazil have identified seven biomarkers that could be used to indicate which glioma patients are likely to experience an aggressive form of the brain cancer.